Market revenue in 2023 | USD 3.7 million |
Market revenue in 2030 | USD 6.6 million |
Growth rate | 8.7% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 59.46% in 2023. Horizon Databook has segmented the Colombia pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing competition & presence of pharmaceutical companies, supporting services for drug development, and regulatory services are expected to propel market growth. In November 2023, Extended expanded its business in Columbia with an investment of USD 7.5 million.
In addition, the rising number of government initiatives to prevent infectious diseases is expected to improve the demand for new & generic drugs in the market. Moreover, a significant Colombian population is suffering from chronic & infectious diseases.
Consequently, the rising number of clinical trials in the country is expected to fuel market growth. According to ClinicaltrialTrials.gov, around 74 studies were registered from 2022 to 2023 in Colombia.
Horizon Databook provides a detailed overview of country-level data and insights on the Colombia pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into Colombia pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account